Vanberra Signal

baseimmune

Curated by Signal

Developer of AI based vaccines for treating infectious diseases

Overview

Developer of AI-based vaccines for treating infectious diseases. The company has developed the BSIvet-001, BSIvet-001, BSIvet-001 vaccines for the treatment of swine fever. It also provides the BSIhum-002 vaccine for the treatment of SARS-CoV-2, malaria, porcine repro and respiratory syndrome

Key facts

Founded
2019

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of nucleic acid detection instruments

    Life Sciences TechnologyNewcastle Upon Tyne, United Kingdom
  • Robotic Navigation System for orthopedic surgery

    Life Sciences TechnologyLondon, United Kingdom
  • Smart footwear for reducing the risk of fall

    Life Sciences TechnologyClapham, United Kingdom

About baseimmune

What does baseimmune do?

Developer of AI-based vaccines for treating infectious diseases.

Where is baseimmune headquartered?

baseimmune is headquartered in London, United Kingdom.

When was baseimmune founded?

baseimmune was founded in 2019.

Which sector is baseimmune in?

baseimmune operates in Life Sciences Technology.

Who are baseimmune's competitors?

Companies similar to baseimmune include Invenirex, Acrobot, and Walk With Path.